SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-18-065109
Filing Date
2018-10-31
Accepted
2018-10-31 16:48:57
Documents
6
Effectiveness Date
2018-10-31

Document Format Files

Seq Description Document Type Size
1 S-8 a18-38191_1s8.htm S-8 106987
2 EX-5.1 a18-38191_1ex5d1.htm EX-5.1 22460
3 EX-23.2 a18-38191_1ex23d2.htm EX-23.2 3233
4 EX-23.3 a18-38191_1ex23d3.htm EX-23.3 4967
5 EX-23.4 a18-38191_1ex23d4.htm EX-23.4 3706
6 GRAPHIC g381911kgi001.jpg GRAPHIC 2064
  Complete submission text file 0001104659-18-065109.txt   145439
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-228094 | Film No.: 181150942
SIC: 2834 Pharmaceutical Preparations